Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “At Risk for HIV”

104 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 104 results

Not applicableEnded earlyNCT03278990
What this trial is testing

Scalable Interventions to Increase PrEP Adherence: Value Affirmation and Future Selves

Who this might be right for
HIV Prevention
Stuart Fisk 26
Not applicableStudy completedNCT04373551
What this trial is testing

WeExPAnd: PrEP Demonstration Project Among Women at Risk for HIV Infection - Preexposure Prophylaxis (PrEP)

Who this might be right for
HIV-infection/AIDS
University of Alabama at Birmingham 67
Not applicableUnknownNCT05520905
What this trial is testing

TelePrEP for At-risk Youth in Colorado

Who this might be right for
Hiv
University of Colorado, Denver 100
Not applicableStudy completedNCT01581086
What this trial is testing

Vascular Subphenotypes of Lung Disease in HIV & COPD

Who this might be right for
Pulmonary Artery Hypertension
University of Pittsburgh 30
Early research (Phase 1)Study completedNCT02895893
What this trial is testing

PrEP SMART Phase I Trial

Who this might be right for
At Risk for HIV
Duke University 12
Large-scale testing (Phase 3)Looking for participantsNCT06633900
What this trial is testing

Naltrexone for Overdose Prevention

Who this might be right for
Overdose Accidental
University of California, San Francisco 100
Testing effectiveness (Phase 2)Study completedNCT01505114
What this trial is testing

Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 594
Post-approval studies (Phase 4)Study completedNCT03642704
What this trial is testing

HIV Diagnosis and Treatment at Birth for Newborn With High Risk HIV Exposure

Who this might be right for
Mother to Child HIV Transmission
ANRS, Emerging Infectious Diseases 56
Testing effectiveness (Phase 2)Ended earlyNCT03201939
What this trial is testing

Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeria

Who this might be right for
HIV/AIDSAlbuminuriaKidney Diseases+1 more
Vanderbilt University Medical Center 66
Not applicableUnknownNCT00080093
What this trial is testing

Increasing Condom Use in People at Risk for HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 534
Not applicableStudy completedNCT02677025
What this trial is testing

Young Women's Health CoOp (Cooperative) in Cape Town

Who this might be right for
HIVSubstance Abuse
RTI International 100
Not applicableStudy completedNCT03974061
What this trial is testing

Brief Acceptance and Commitment Therapy for HIV-infected At-risk Drinkers

Who this might be right for
Treatment
Syracuse University 49
Not applicableStudy completedNCT01876199
What this trial is testing

Targeted Screening of At-Risk Adults for Acute HIV-1 Infection

Who this might be right for
HIV
University of Oxford 522
Large-scale testing (Phase 3)Study completedNCT02526212
What this trial is testing

Buprenorphine Group Medical Visits in Primary Care

Who this might be right for
Opioid-Related Disorders
Montefiore Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT00338845
What this trial is testing

Share Safer Sex Counseling Program for Changing Sexual Risk Behaviors in Mexican Female Sex Workers

Who this might be right for
HIV InfectionsSexually Transmitted Diseases
University of California, San Diego 1,800
Large-scale testing (Phase 3)Ended earlyNCT04652700
What this trial is testing

Oral Islatravir (MK-8591) Once-Monthly as Preexposure Prophylaxis (PrEP) in Men and Transgender Women Who Are at High Risk for HIV-1 Infection (MK-8591-024)

Who this might be right for
HIV Preexposure Prophylaxis
Merck Sharp & Dohme LLC 494
Not applicableStudy completedNCT03235518
What this trial is testing

A Combination HIV Prevention Strategy for Young Women at Risk for HIV

Who this might be right for
Human Immunodeficiency Virus
Columbia University 329
Not applicableUnknownNCT06242730
What this trial is testing

Doxycycline PEP and 4CMenB as a Comprehensive Prevention Strategy in MSM and TGW at High Risk for Bacterial STIs Within the Swiss HIV Cohort Study

Who this might be right for
Doxycycline STI PEP
University of Zurich 400
Large-scale testing (Phase 3)Active Not RecruitingNCT04994509
What this trial is testing

Pre-Exposure Prophylaxis Study of Lenacapavir and Emtricitabine/Tenofovir Alafenamide in Adolescent Girls and Young Women at Risk of HIV Infection

Who this might be right for
Pre-Exposure Prophylaxis of HIV Infection
Gilead Sciences 5,368
Testing effectiveness (Phase 2)WithdrawnNCT05115838
What this trial is testing

Radiopaque Matrix MK-8591 Implant in Participants at Low-Risk for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591-043)

Who this might be right for
Human Immunodeficiency VirusHIV
Merck Sharp & Dohme LLC
Next Page